About Spiration
Spiration is a company based in Redmond (United States) founded in 1999 was acquired by Olympus America in June 2010. Spiration has raised $73.9 million across 6 funding rounds from investors including Boston Scientific, Credit Suisse and New Leaf Venture Partners. The company has 74 employees as of December 31, 2015. Spiration offers products and services including Spiration Valve System. Spiration operates in a competitive market with competitors including Pulmonx, Neurent Medical, Gradient Denervation Technologies, Uptake Medical and Emphasys Medical, among others.
- Headquarter Redmond, United States
- Employees 74 as on 31 Dec, 2015
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Spiration, Inc
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$73.9 M (USD)
in 6 rounds
-
Latest Funding Round
$6.5 M (USD), Debt – Conventional
Apr 29, 2010
-
Investors
Boston Scientific
& 8 more
-
Employee Count
74
as on Dec 31, 2015
-
Acquired by
Olympus America
(Jun 25, 2010)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Spiration
Spiration offers a comprehensive portfolio of products and services, including Spiration Valve System.
Minimally-invasive therapy to treat severe emphysema via valve placement
Funding Insights of Spiration
Spiration has successfully raised a total of $73.9M across 6 strategic funding rounds. The most recent funding activity was a Debt – Conventional round of $6.5 million completed in April 2010. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Spiration
Spiration has secured backing from 9 investors, including venture fund and institutional investors. Prominent investors backing the company include Boston Scientific, Credit Suisse and New Leaf Venture Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital firm managing investments in biotechnology and pharmaceuticals since 1999.
|
Locked | Locked | Locked | |
|
Venture capital investments are offered to startups by NEA.
|
Locked | Locked | Locked | |
|
Stage-agnostic investments in US life sciences are managed.
|
Locked | Locked | Locked |
Investor details for Spiration
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Spiration
Investment portfolio details for Spiration
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Spiration
Detailed financials for Spiration
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Spiration Comparisons
Peer comparison for Spiration
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Spiration
Spiration operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Pulmonx, Neurent Medical, Gradient Denervation Technologies, Uptake Medical and Emphasys Medical, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Developer of smart devices for treating pulmonary diseases
|
|
| Locked | Locked | Locked |
Smart devices for minimally invasive rhinitis treatment are developed.
|
|
| Locked | Locked | Locked |
Endovascular catheter-based technology for pulmonary hypertension treatment is provided.
|
|
| Locked | Locked | Locked |
Targeted vapor therapy is developed for endoscopic lung volume reduction.
|
|
| Locked | Locked | Locked |
Endobronchial valves for emphysema treatment are developed.
|
Detailed competitors of Spiration
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Spiration
Complete news archive for Spiration
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Spiration
Spiration was founded in 1999 and raised its 1st funding round 3 years after it was founded.
Spiration is headquartered in Redmond, United States. It is registered at Redmond, Washington, United States.
Spiration is a funded company, having raised a total of $73.9M across 6 funding rounds to date.
As of Dec 31, 2015, the latest employee count at Spiration is 74.
Spiration, develops medical devices for the treatment of air leaks and lung diseases. It developed the IBV Valve system to treat severely diseased lung in patients with heterogeneous emphysema and evidence or markers of low collateral ventilation such as complete fissures, or damaged lung resulting in air leaks, by limiting airflow to selected areas. The Spiration Valve blocks incoming breath from entering damaged portions of the lung, while it permits trapped air and mucus to escape the damaged and potentially hyper-inflated lung. It has received CE Mark regulatory approval, TGA approval in Australia, a humanitarian device exemption for treating prolonged air leaks in the United States, and CFDA approval in China and Health Canada approval for treating air leaks. As of 2010, Spiration operates as a subsidiary of Olympus America.
Spiration's top competitors include Pulmonx, Neurent Medical and Gradient Denervation Technologies.
Spiration offers Spiration Valve System.
Spiration has 9 investors. Key investors include Boston Scientific, Credit Suisse, New Leaf Venture Partners, Olympus America, and Versant Ventures.